Drs Robert Glatter and Ken Milne discuss what the recent RSI trial reveals — and does not reveal — about choosing etomidate ...

The new model, called Scope AI, is addressing a very real problem: There aren't nearly enough doctors visiting encampments ...

Akido Labs, an LA-based health care technology company that runs clinics and street medicine teams in California, plans to ...

A MUM who has lost almost half her body weight thanks to Mounjaro has revealed the three mistakes new jabbers are making – ...

Sacramento and Stanislaus counties are at a “higher risk,” while San Joaquin County is at a “very high risk,” the interactive map says.

The new model, called Scope AI, is addressing a very real problem: There aren’t nearly enough doctors visiting encampments ...

Sir Keir Starmer's January has been the stuff of nightmares.

Mid-stage trial data showed Roche's experimental shot delivered weight loss on par with leading obesity treatments, ...

A California company is using AI to help diagnose homeless Californians. The technology promises better access to health care ...

Here & Now’s Peter O’Dowd spoke with Sarah Zhang, a reporter for The Atlantic, about how people are searching the web and using the app Telegram to buy next-generation GLP-3 drugs not yet approved by ...

This specific 1-29 sequence is often referred to as the "functional fragment" because it contains the essential binding domain required to activate GHRH receptors in the pituitary gland.